Titration of signalling output: insights into clinical combinations of MEK and AKT inhibitors

por Stewart, A., Thavasu, P., de Bono, J. S., Banerji, U.
Publicado 2015

Association of creatine kinase and skin toxicity in phase I trials of anticancer agents

por Moreno Garcia, V, Thavasu, P, Blanco Codesido, M, Molife, L R, Vitfell Pedersen, J, Puglisi, M, Basu, B, Shah, K, Iqbal, J, de Bono, J S, Kaye, S B, Banerji, U
Publicado 2012

Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer

por Jones, P H, Christodoulos, K, Dobbs, N, Thavasu, P, Balkwill, F, Blann, A D, Caine, G J, Kumar, S, Kakkar, A J, Gompertz, N, Talbot, D C, Ganesan, T S, Harris, A L
Publicado 2004